Inventor · disambiguated record
Joseph Schuh
Also filed as: SCHUH JOSEPH R
5 granted patents·16 pending applications·187 citations·filing 1997–2005
83Inventor score
Top patents by PatentIndex Score
21 records- 0189US6653306B1Epoxy-steroidal aldosterone antagonist and angiotensin II antagonist combination therapySEARLE & CO·Filed 1997·Granted Nov 25, 2003·105 cites·34 claims
- 0278US6562860B1Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indicationsSEARLE & CO·Filed 1999·Granted May 13, 2003·39 cites·11 claims
- 0377US6458851B1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 1, 2002·35 cites·8 claims
- 0474US6984633B2Method to treat cardiofibrosis with a combination therapy of an angiotensin II antagonist and epoxymexrenoneSEARLE & CO·Filed 2003·Granted Jan 10, 2006·7 cites·24 claims
- 0555US2004235809A1Epoxy steroidal aldosterone antagonist and beta-adremergic antagonist combination therepy for treatment of congestive heart failureFiled 2001·Application pending·0 cites
- 0655US2002123485A1Epoxy steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failureFiled 2001·Application pending·0 cites
- 0753US2005215537A1Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failurePHARMACIA CORP·Filed 2005·Application pending·0 cites
- 0849US2004048846A1Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 2003·Application pending·0 cites
- 0949US2004097549A1Method and composition for administering a cyclooxygenase-2 inhibitorPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 1049US2004067915A1Method to treat cardiofibrosis with a combination of an angiotensin II antagonist and spironolactoneSEARLE & CO·Filed 2003·Application pending·0 cites
- 1148US2004029845A1Combinations of ileal bile acid transport inhibitors and bile acid sequestering agents for cardiovascular indicationsSEARLE & CO·Filed 2003·Application pending·0 cites
- 1248US2003220312A1Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of cardiovascular disordersSEARLE & CO·Filed 2002·Application pending·0 cites
- 1347US2003203892A1Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein inhibitors for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 1444US2003220310A1Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failureFiled 2001·Application pending·0 cites
- 1544US2004101523A1Renal-selective prodrugs for control of renal smpathetic nerve activity in the treatment of hypertensionSEARLE & CO·Filed 2003·Application pending·0 cites
- 1644US2003220521A1Renal-selective prodrugs for control of renal sympathetic nerve activity in the treatment of hypertensionSEARLE & CO·Filed 2002·Application pending·0 cites
- 1743US2002009421A1Therapy following skin injury from exposure to ultraviolet radiationFiled 2001·Application pending·0 cites
- 1842US2002042405A1Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failureFiled 2001·Application pending·0 cites
- 1940US2004102423A1Spironolactone and angiotensin II antagonist combination therapy for treatment of congestive heart failureSEARLE & CO·Filed 2002·Application pending·0 cites
- 2039US2004058908A1Combinations for cardiovascular indicationsSEARLE LLC·Filed 2002·Application pending·0 cites
- 2134US6638969B1Combinations of ileal bile acid transport inhibitors and fibric acid derivatives for cardiovascular indicationsSEARLE LLC·Filed 1999·Granted Oct 28, 2003·1 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Joseph Schuh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →